B. Mayor

发表

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study

G. Jean, J. Hurot, C. Lorriaux, 2015, BMC Nephrology.

Evidence for Persistent Vitamin D 1-Alpha-Hydroxylation in Hemodialysis Patients: Evolution of Serum 1,25-Dihydroxycholecalciferol after 6 Months of 25-Hydroxycholecalciferol Treatment

C. Chazot, J. Terrat, T. Vanel, 2008, Nephron Clinical Practice.

Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort

J. Souberbielle, M. Lafage-Proust, C. Chazot, 2018, PloS one.

Increased Levels of Serum Parathyroid Hormone and Fibroblast Growth Factor-23 Are the Main Factors Associated with the Progression of Vascular Calcification in Long-Hour Hemodialysis Patients

C. Chazot, G. Jean, J. Hurot, 2012, Nephron Clinical Practice.

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.

C. Chazot, J. Terrat, T. Vanel, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.

C. Chazot, J. Terrat, T. Vanel, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vascular Calcification Progression Is an Independent Predictor of Mortality in Patients on Haemodialysis

C. Chazot, G. Jean, J. Hurot, 2015, Nephron.

Even a Moderate Fluid Removal Rate during Individualised Haemodialysis Session Times Is Associated with Decreased Patient Survival

C. Chazot, G. Jean, J. Hurot, 2017, Blood Purification.

Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.

C. Chazot, T. Vanel, G. Jean, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Treating mineral metabolism disorders in patients undergoing long hemodialysis: A search for an optimal strategy

C. Chazot, J. Terrat, T. Vanel, 2009, Hemodialysis international. International Symposium on Home Hemodialysis.

Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients

C. Chazot, G. Jean, J. Hurot, 2017, Cardiorenal Medicine.

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

C. Chazot, J. Terrat, T. Vanel, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients

J. Souberbielle, C. Chazot, G. Jean, 2016, BMC Nephrology.

Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone.

C. Chazot, G. Jean, J. Hurot, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].

C. Chazot, J. Terrat, T. Vanel, 2010, Nephrologie & therapeutique.

Predialysis Systolic Blood Pressure Evolution in Incident Hemodialysis Patients: Effects of the Dry Weight Method and Prognostic Value

C. Chazot, G. Jean, J. Hurot, 2012, Blood Purification.

Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease.

J. Souberbielle, C. Chazot, G. Jean, 2012, Clinical biochemistry.

[Calciphylaxis in dialysis patients: To recognize and treat it as soon as possible].

C. Chazot, J. Terrat, T. Vanel, 2010, Néphrologie & Thérapeutique.

Predicting Glomerular Filtration Rate in Kidney Transplantation: Are the K/DOQI Guidelines Applicable?

L. Thibaudin, F. Berthoux, C. Mariat, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[An efficient strategy to decrease the central venous catheter-related adverse events rate in haemodialysis patients].

C. Chazot, J. Terrat, T. Vanel, 2009, Nephrologie & therapeutique.

Target Weight Gain during the First Year of Hemodialysis Therapy Is Associated with Patient Survival

C. Chazot, G. Jean, J. Hurot, 2014, Nephron Clinical Practice.